@rogevibe wrote:
@4channel wrote:
@viewmont1071 wrote:
A typical HCQ regimen is 200 mg bid for 5 days and extended to 30 days for continued symptoms.
A minimal sufficient dose of HCQ should be used, because in excessive doses the drug can interfere with early immune response to the virus."
A proper guideline should be set out.
The below was originally posted by rogespeed
Re: coronavirus vaccine, who should get it first?in reply to 4channel
on 11-29-2020 08:34 PM
@rogespeed wrote:
@4channel wrote:
Well, best to look at promoting good health and well-being before considering a rush vaccine pushed out by a greed-driven Big Pharma.for those that do not need immediate hospitalisation
‘Only a one in 17 billion chance hydroxychloroquine doesn’t work’: medical professor (msn.com)
A better link for the same clip is below
https://www.youtube.com/watch?v=WdsAVTkSDhM
It also needs to be noted that in treatment of Coviid 19 during the early stages ( as mentioned by Dr. Peter McCullough ), hydroxochlorquine isn't the only drug taken. two other drugs plus zinc need to be taken with it.
Like a lot of things which are effective but they are not much of a money spinner to Big Pharma, the valuable information on this treatment is not promoted. We only have to look at The Cancer Industtry to see great potential courses for recovery are avoided in favour of something that makes money but may not benefit the patient.
Below is informative as well.
Vitamin D and COVID 19: The Evidence for Prevention and Treatment of Coronavirus (SARS CoV 2)
4,530,139 views•Premiered Dec 10, 2020939K subscribers
https://www.youtube.com/watch?v=ha2mLz-Xdpg
BTW: What better way to demonise and mock a treatment by calling it "Trump's Treatment". A useful idiot!
--- --- --- --- --- --- --- --- --- ---
People before profit please!
people before profit : One might have to contribute more in taxes for a higher priority
Vitamin D - exposure to sunshine ? or if in hospital exposure to sunshine spectrum lighting ?
https://clinicalmolecularallergy.biomedcentral.com/articles/10.1186/s12948-020-00139-0
